Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM)

NCT02586857

Conditions
Astrocytoma, Chronic Disease, Disease Attributes, +22 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study of ACP-196 (Acalabrutinib) in Subjects With Relapsed/Refractory CLL and Intolerant of Ibrutinib Therapy

NCT02717611

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Concord, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Palo Alto, California, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma

NCT04268498

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

NCT03534323

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Miami- Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Northern Light Eastern Maine Medical Center Brewer, Maine, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

NCT02773030

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Local Institution - 102 Scottsdale, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Local Institution - 107 Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 162 locations
View Trial Details

Related conditions